Inflammatory and blood gas markers of COVID-19 delirium compared to non-COVID-19 delirium: a cross-sectional study.

  title={Inflammatory and blood gas markers of COVID-19 delirium compared to non-COVID-19 delirium: a cross-sectional study.},
  author={Aman Saini and Tae Hyun Oh and Dory Anthony Ghanem and Megan Castro and Matthew Butler and Chun Chiang Sin Fai Lam and Sotiris Posporelis and Glyn Lewis and Anthony S. David and Jonathan P. Rogers},
  journal={Aging \& mental health},
OBJECTIVES We aimed to find the association of inflammation and respiratory failure with delirium in COVID-19 patients. We compare the inflammatory and arterial blood gas markers between patients with COVID-19 delirium and delirium in other medical disorders. METHODS This cross-sectional study used the CHART-DEL, a validated research tool, to screen patients for delirium retrospectively from clinical notes. Inflammatory markers C-reactive protein (CRP) and white cell count (WBC), and the… 

Figures and Tables from this paper

Factors Associated with Delirium in COVID-19 Patients and Their Outcome: A Single-Center Cohort Study
Delirium was the strongest predictor of poor outcome in COVID-19 patients, especially in the hypoactive subtype, and several clinical features and inflammatory markers were associated with the increased risk of its occurrence.


Correlation of refractory hypoxemia with biochemical markers and clinical outcomes of COVID-19 patients in a developing country: A retrospective observational study
Neutrophil-to-Lymphocyte ratio, C-reactive protein, and Lactate dehydrogenase were effective biomarkers in predicting a severe course of COVID-19, but could not establish significant associations of serum Ferritin, Procalcitonin, and D-Dimer.
Delirium and Mortality in Coronavirus Disease 2019 (COVID-19) – A Systematic Review and Meta-analysis
The impact of delirium on outcomes for older adults hospitalised with COVID-19
Delirium is common in older patients with COVID-19 and strongly associated with in-hospital mortality and Regardless of causation, either due to a direct effect of SARS-COV-2 on the CNS or to a multifactorial cause, delirium should be interpreted as an alarming prognostic indicator in older people.
Prevention, diagnosis, and treatment of delirium in older adults with COVID-19. Literature review
Delirium is a frequent neurological manifestation in OA with COVID-19 and requires early identification, as well as the implementation of non-pharmacological and pharmacological treatment strategies, which may reduce the associated morbidity and mortality in this age group.
Association of inflammatory markers with the severity of COVID-19: A meta-analysis
Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study
Lymphopenia at an early stage aggravates the severity and elevates the death risk of COVID-19 patients, and older age was a risk factor of lymphopenia.
Clinical Characteristics and Outcomes of 821 Older Patients With SARS-Cov-2 Infection Admitted to Acute Care Geriatric Wards
A quick bedside evaluation at admission of sex, functional status, systolic arterial pressure, consciousness, respiratory rate, and asthenia can identify older patients at risk of unfavorable outcomes.